Thereby, GPA33 constitutes an ideal antigen for the development of colorectal cancer-directed immunotoxins and thus was employed as the target of different immunotoxins already designed by our group [15,16,17,18,19,20]. The gene discussed is GPA33; the disease is colorectal cancer.